A Global Perspective

The 2017 International Myeloma Workshop: Well-Deserved Awards, Exciting Glimpses of the Future, Limits on Global Access

Myeloma experts from around the world gathered in New Delhi last week to offer summaries of the latest in research, honor several outstanding researchers, and predict what the future might hold for patients. The excitement over new treatment options was accompanied by concern over availability outside the US. In his blog this week, IMF Chairman Dr. Brian Durie notes that “the lack of early or proper diagnosis and severe lack of access to most of the newer therapies is substantially reducing outcomes.” To read Dr. Durie’s blog, click HERE.

Pre-Register Now for the Next "Living Well with Myeloma" Teleconference

Register for this FREE 45-minute “Living Well with Myeloma” teleconference followed by a 15-minute Q&A from callers, on Thursday, March 23rd at 7 PM ET / 4 PM PT. The topic will be Novel Agents & Clinical Trials, hosted by Dr. Craig Cole of the University of Michigan. Pre-register HERE now.

 

Join Thunderclap to Take Your Action for Myeloma Action Month

Join the IMF and Amgen as we take action to raise awareness with a Myeloma Action Month Thunderclap. Sign up HERE with your Twitter or Facebook account. Then, on March 24th at 12 PM PT, a message will automatically be sent from your designated social media account that shows your support for Myeloma Action Month.

 

Ask Your House Representative to Support Myeloma Action Month

The IMF Advocacy team is working on H.R. 148, a federal proclamation to designate March as Myeloma Action Month. H.R. 148 has been submitted in the House, and the next step is to encourage representatives to sign on. Click HERE and fill out this form to push this proclamation; it takes less than 3 minutes.

 

 

Help the Southeastern Virginia Multiple Myeloma Support Group Raise Funds

This Myeloma Action Month, the Southeastern Virginia Multiple Myeloma Support Group, which formed in 2007, is spearheading a FUNdraiser to raise myeloma awareness and increase funds for patient education and support programs. Learn about and donate toward their efforts HERE.

 

 


We Would Like to Thank Our Sponsors: Takeda, Celgene, Amgen, and Bristol-Myers Squibb